---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279729863.md"
description: "The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declines"
datetime: "2026-03-19T06:30:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279729863.md)
  - [en](https://longbridge.com/en/news/279729863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279729863.md)
---

# 

The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had the largest declines

### Related Stocks

- [300016.CN](https://longbridge.com/en/quote/300016.CN.md)
- [688136.CN](https://longbridge.com/en/quote/688136.CN.md)
- [688710.CN](https://longbridge.com/en/quote/688710.CN.md)
- [688488.CN](https://longbridge.com/en/quote/688488.CN.md)
- [300683.CN](https://longbridge.com/en/quote/300683.CN.md)
- [688131.CN](https://longbridge.com/en/quote/688131.CN.md)

## Related News & Research

- [20:17 ETÜber den Horizont hinaus, gemeinsam immer weiter | Kexing Biopharm zieht Bilanz für seine Teilnahme an der CPHI & PMEC China 2026](https://longbridge.com/en/news/290752726.md)
- [23:39 ETBeyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026](https://longbridge.com/en/news/290639584.md)
- [Yuyantang Seeks Hong Kong IPO Amid Policy Backing For Traditional Chinese Medicine](https://longbridge.com/en/news/294970152.md)
- [Prediction: These 2 stocks will keep winning no matter what the market does](https://longbridge.com/en/news/294863847.md)
- [BeOne Medicines publishes Q2 clinical trials portfolio presentation detailing pipeline and study updates](https://longbridge.com/en/news/294973584.md)